IRONWOOD PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Debt Securities, Available-for-sale, Current of $19.84 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2019-02-25
- 2018-09-30: Debt Securities, Available-for-sale, Current $19.84M.
- 2018-06-30: Debt Securities, Available-for-sale, Current $35.83M.
- 2018-03-31: Debt Securities, Available-for-sale, Current $49.66M.
- 2017-12-31: Debt Securities, Available-for-sale, Current $95.68M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2018-09-30 | $19.84M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $35.83M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $49.66M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $95.68M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |